MarketPeel
Insider Trading Intelligence
Pricing
…
MS

Mark Schoenberg

URGN
CHIEF MEDICAL OFFICER · UROGEN PHARMA LTD. · CIK 0001763581
FILING MIX · LIFETIME38%/62%
BUYS
54
SELLS
89
TOTAL VALUE
$2.69M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
129,763
AVG SELL PX
$20.20
TRADE KIND
SHOWING 143 / 143
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
45 backtested trades · 8 horizons · 26 pending
Forward-return performance of every backtestable P/S trade by Mark Schoenberg, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d45+44.44%+5.33%+0.88%+4.45%+1.98%1.63
14d45+44.44%+4.51%+1.45%+3.12%-0.81%1.03
30d45+66.67%-2.79%+1.39%-4.18%-2.51%-1.46
60d45(1 pending)+68.18%-4.00%+1.60%-5.61%-12.17%-1.29
90d45(1 pending)+54.55%+2.86%+3.14%-0.28%-6.14%-0.05
180d45(4 pending)+56.10%+8.47%+7.80%+0.67%-12.88%0.08
1y45(8 pending)+64.86%+3.32%+14.50%-11.19%-39.23%-0.94
2y45(12 pending)+42.42%+4.01%+26.46%-22.45%-27.99%-2.15
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
URGN · 129,763 shares · as of Jun 22, 2026
040,84581,689122,534163,378202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 54 buys / 89 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
URGN
UROGEN PHARMA LTD.
SALE10b5-1
10b5-1 plan
10,000$35.01$350.1K129,763Jun 22, 2026Jun 23, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
10,000——0Jun 8, 2026Jun 9, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
10,000——144,985Jun 8, 2026Jun 9, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
5,222$27.30$142.6K139,763Jun 8, 2026Jun 9, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE10b5-1
10b5-1 plan
10,000$30.00$300.0K134,985May 8, 2026May 11, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
3,686$19.69$72.6K144,985Feb 3, 2026Feb 4, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,844$19.69$36.3K150,514Feb 3, 2026Feb 4, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,843$19.69$36.3K148,671Feb 3, 2026Feb 4, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
3,334——142,359Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
3,334——0Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
3,333——3,334Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
6,666——13,334Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
20,000——20,000Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
6,666——152,358Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
3,333——145,692Jan 31, 2026Feb 3, 2026 ↗View →
URGN
UROGEN PHARMA LTD.
SALE10b5-1
10b5-1 plan
10,000$25.00$250.0K139,025Nov 19, 2025Nov 20, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
871$19.11$16.6K149,025Sep 8, 2025Sep 9, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,667——149,896Sep 7, 2025Sep 9, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,667——1,667Sep 7, 2025Sep 9, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
10,000$17.69$176.9K148,229Aug 11, 2025Aug 13, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
10,000——163,378Jul 28, 2025Jul 30, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
5,149$19.14$98.6K158,229Jul 28, 2025Jul 30, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
5,162$7.37$38.0K153,378Jun 9, 2025Jun 10, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
10,000——10,000Jun 8, 2025Jun 10, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
10,000——158,540Jun 8, 2025Jun 10, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,334——0Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
3,333——148,999Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
759$11.14$8.5K145,666Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
3,333——6,667Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,334——146,425Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
3,333——150,436Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,896$11.14$21.1K148,540Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
20,000——20,000Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
3,333——3,334Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,896$11.14$21.1K147,103Jan 31, 2025Feb 4, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
859$13.08$11.2K145,091Sep 9, 2024Sep 12, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,666——3,334Sep 9, 2024Sep 12, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,666——145,950Sep 9, 2024Sep 12, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
5,153$13.08$67.4K144,284Jun 10, 2024Jun 11, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
10,000——20,000Jun 10, 2024Jun 11, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
10,000——149,437Jun 10, 2024Jun 11, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
12,000$14.05$168.6K139,437Mar 18, 2024Mar 20, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,894$15.78$29.9K151,437Feb 1, 2024Feb 5, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
758$15.78$12.0K149,998Feb 1, 2024Feb 5, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,137$15.78$17.9K149,423Feb 1, 2024Feb 5, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
2,000——150,560Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
2,000——0Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,137$15.74$17.9K149,423Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
758$15.74$11.9K149,998Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,333——1,334Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,333——150,756Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,894$15.74$29.8K151,437Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
3,333——6,667Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
3,333——153,331Jan 31, 2024Feb 2, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
5,000——5,000Sep 7, 2023Sep 8, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 8, 2023Jun 9, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
2,000——2,000Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,333——2,667Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——147,127Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
991$10.12$10.0K147,888Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
30,000——30,000Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——0Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,333——149,221Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
248$10.12$2.5K146,879Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
661$10.12$6.7K148,560Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
2,000——148,879Jan 31, 2023Feb 2, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
122,677——0Jan 20, 2023Jan 23, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
122,677$5.00$613.4K146,627Jan 20, 2023Jan 23, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
258$11.85$3.1K23,950Oct 31, 2022Nov 2, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——500Oct 31, 2022Nov 2, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——24,208Oct 31, 2022Nov 2, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
259$7.81$2.0K23,708Aug 1, 2022Aug 25, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——1,000Jul 31, 2022Aug 25, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——23,967Jul 31, 2022Aug 25, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
254$6.62$1.7K23,467Apr 30, 2022May 3, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——1,500Apr 30, 2022May 3, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——23,721Apr 30, 2022May 3, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
12,064——12,064Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
275$7.58$2.1K22,320Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
2,000——4,000Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,099$7.58$8.3K23,221Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
2,000——24,320Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
4,000——4,000Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——2,000Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——22,595Jan 31, 2022Feb 1, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
209——22,206Jan 26, 2022Jan 28, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
209——0Jan 26, 2022Jan 28, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
111$8.09$89822,095Jan 26, 2022Jan 28, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
160$13.10$2.1K21,997Nov 18, 2021Nov 18, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
258$17.16$4.4K21,837Nov 1, 2021Nov 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——22,095Oct 31, 2021Nov 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——2,500Oct 31, 2021Nov 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
107$16.32$1.7K21,595Oct 27, 2021Oct 28, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
208——21,702Oct 26, 2021Oct 28, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
208——209Oct 26, 2021Oct 28, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
243$15.64$3.8K21,494Aug 2, 2021Aug 3, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——21,737Jul 31, 2021Aug 3, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——3,000Jul 31, 2021Aug 3, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
103$15.30$1.6K20,821Jul 26, 2021Jul 27, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
208——417Jul 26, 2021Jul 27, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
208——20,924Jul 26, 2021Jul 27, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
243$20.00$4.9K21,132Apr 30, 2021May 4, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
500——3,500Apr 30, 2021May 4, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
500——21,375Apr 30, 2021May 4, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
209——625Apr 26, 2021Apr 27, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
209——20,964Apr 26, 2021Apr 27, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
89$19.63$1.7K20,875Apr 26, 2021Apr 27, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
6,000——6,000Jan 31, 2021Feb 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
2,000——4,000Jan 31, 2021Feb 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
21,000——21,000Jan 31, 2021Feb 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
2,000——21,831Jan 31, 2021Feb 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,076$22.07$23.7K20,755Jan 31, 2021Feb 2, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
208——834Jan 26, 2021Jan 26, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
100$22.12$2.2K19,831Jan 26, 2021Jan 26, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
208——19,931Jan 26, 2021Jan 26, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
662$19.85$13.1K19,723Dec 4, 2020Dec 7, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,042——20,385Dec 4, 2020Dec 7, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,042——0Dec 4, 2020Dec 7, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
101$20.95$2.1K19,343Oct 26, 2020Oct 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
208——19,444Oct 26, 2020Oct 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
208——1,042Oct 26, 2020Oct 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
348$20.20$7.0K19,236Sep 4, 2020Sep 8, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,041——1,042Sep 4, 2020Sep 8, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,041——19,584Sep 4, 2020Sep 8, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
70$23.51$1.6K18,543Jul 27, 2020Jul 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
209——1,250Jul 26, 2020Jul 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
209——18,613Jul 26, 2020Jul 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,042——2,083Jun 4, 2020Jun 5, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,042——18,753Jun 4, 2020Jun 5, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
349$27.51$9.6K18,404Jun 4, 2020Jun 5, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
70$24.35$1.7K17,711Apr 27, 2020Apr 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
208——1,459Apr 26, 2020Apr 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
208——17,781Apr 26, 2020Apr 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
345$29.50$10.2K17,573Mar 4, 2020Mar 4, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
1,042——17,918Mar 4, 2020Mar 4, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
1,042——3,125Mar 4, 2020Mar 4, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
15,000——15,000Jan 31, 2020Feb 3, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
6,000——6,000Jan 31, 2020Feb 3, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
322$29.15$9.4K9,177Jan 27, 2020Jan 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
SALE
Chief Medical Officer
833——1,667Jan 26, 2020Jan 28, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASE
Chief Medical Officer
833——9,499Jan 26, 2020Jan 28, 2020 ↗View →
Other insiders · URGN
Loading peer insiders…
About this filer
CIK 0001763581
ROLE
Chief Medical Officer
PRIMARY
URGN
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001763581DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback